30 Stocks Moving In Monday's Pre-Market Session

Gainers

• VirnetX Holding Corporation VHC rose 28.2 percent to $5.00 in pre-market trading after falling 2.50 percent on Friday.
• Synchronoss Technologies, Inc. SNCR gained 23.5 percent to $11.52 after the company disclosed Friday that it remains in active discussions with multiple parties.
• ITUS Corp ITUS rose 17.1 percent to $3.08 in pre-market trading after falling 24.86 percent on Friday. ITUS reported the completion of at-the-market offering.
• Arbutus Biopharma Corp ABUS rose 17 percent to $7.25 in pre-market trading after the company disclosed that it will receive a $116 million strategic investment from Roivant Sciences.
• Rigel Pharmaceuticals, Inc. RIGL rose 14.2 percent to $2.90 in the pre-market trading session after the company issued an update on FDA review of fostamatinib for ITP.
• MannKind Corporation MNKD shares rose 12.4 percent to $2.44 in pre-market trading after the company disclosed that the FDA has approved an update to the Afrezza prescribing information.
• Trinity Industries Inc TRN shares rose 12.4 percent to $35.85 in pre-market trading after gaining 2.31 percent on Friday.
• Kitov Pharmaceuticals Holdings Ltd (ADR) KTOV rose 11.2 percent to $2.38 in pre-market trading after the company reported filing by FDA for NDA of KIT-302.
• Altice USA Inc ATUS rose 11 percent to $30.30 in pre-market trading. Disney and Altice disclosed an agreement in principle in programming talks and extend deadline to finalize terms, Reuters reported.
• Dynavax Technologies Corporation DVAX shares rose 10.7 percent to $23.80 in the pre-market trading session after gaining 1.18 percent on Friday.
• Intelsat SA I shares rose 10.6 percent to $5.20 in pre-market trading after falling 1.88 percent on Friday.
• Helios and Matheson Analytics Inc HMNY shares rose 10.3 percent to $14.00 in pre-market trading after surging 16.74 percent on Friday.
• AcelRx Pharmaceuticals Inc ACRX rose 8.7 percent to $5.00 in pre-market trading after gaining 5.75 percent on Friday.
• Veritone Inc VERI shares rose 7.8 percent to $49.00 in the pre-market trading session after climbing 23.24 percent on Friday.
• Catabasis Pharmaceuticals Inc CATB rose 7.6 percent to $2.28 in pre-market trading after falling 4.93 percent on Friday.
• Accelerate Diagnostics Inc AXDX shares rose 7 percent to $24.00 in pre-market trading after gaining 1.13 percent on Friday.
• Seattle Genetics, Inc. SGEN rose 6.6 percent to $58.00 in pre-market trading as the company disclosed that it has received the FDA Breakthrough Therapy Designation for ADCETRIS in frontline advanced Hodgkin lymphoma.
• Social Reality Inc SRAX rose 6.4 percent to $2.66 in pre-market trading after surging 31.58 percent on Friday.
• Alnylam Pharmaceuticals, Inc. ALNY rose 4.9 percent to $123.23 in pre-market trading. Goldman Sachs upgraded Alnylam Pharmaceuticals from Neutral to Buy.
• Sarepta Therapeutics Inc SRPT rose 3.6 percent to $47.00 in pre-market trading. Morgan Stanley upgraded Sarepta Therapeutics from Equal-Weight to Overweight.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Biohaven Pharmaceutical Holding Co Ltd BHVN fell 19.7 percent to $30.00 in pre-market trading after the company reported topline data from spinocerebellar ataxia Phase 2/3 trial.
• Roku Inc ROKU fell 9 percent to $24.16 in pre-market trading after jumping 12.94 percent on Friday.
• Nordstrom, Inc. JWN shares fell 6.2 percent to $44.25 in pre-market trading following NY Post report that talks to take the company private may fall apart.
• Tonix Pharmaceuticals Holding Corp. TNXP fell 5.7 percent to $4.30 in pre-market trading after gaining 4.11 percent on Friday.
• 21Vianet Group Inc VNET shares fell 5.1 percent to $5.40 after rising 0.71 percent on Friday.
• MGM Resorts International MGM shares fell 4.9 percent to $31.00 in pre-market trading following Mandaly Bay casino shooting.
• Aradigm Corporation ARDM fell 4.3 percent to $4.02 in pre-market trading after gaining 8.25 percent on Friday.
• bluebird bio Inc BLUE shares fell 4 percent to $131.90 in pre-market trading. Morgan Stanley downgraded bluebird bio from Equal-Weight to Underweight.
• Ominto Inc OMNT shares fell 4 percent to $4.33 in pre-market trading after dipping 22.68 percent on Friday.
• RedHill Biopharma Ltd - ADR RDHL shares fell 3.3 percent to $10.45 in pre-market trading after the company reported acceleration of RHB-104 Phase III study in Crohn's disease.